BROADCASTS.com

In his weekly clinical update, Dr. Griffin discusses estimates of SARS-CoV-2 seroprevalence and incidence of primary SARS-CoV-2 infections among blood donors, by COVID-19 vaccination status, smart thermometer\u2013based participatory surveillance to discern the role of children in household viral transmission during the COVID-19 pandemic, COVID-19 vaccine mandates, changing severity and epidemiology of adults hospitalized with COVID-19 in the United States after introduction of COVID-19 vaccines, effectiveness of COVID-19 treatment with Nirmatrelvir\u2013Ritonavir or Molnupiravir among U.S. veterans, national trends in anticoagulation therapy for COVID-19 hospitalized adults in the United States, development of a definition of postacute sequelae of SARS-CoV-2 infection, neuroinflammation after COVID-19 with persistent depressive and cognitive symptoms, long COVID clinical phenotypes up to six months after infection identified by latent class analysis of self-reported symptoms, and coronary microvascular health in symptomatic patients with prior COVID-19 infection.

Subscribe (free):\xa0Apple Podcasts,\xa0Google Podcasts,\xa0RSS,\xa0email

Become a\xa0patron\xa0of\xa0TWiV!

• Estimates\xa0of SARS-CoV-2 seroprevalence and incidence of infections among blood donors, by vaccination status (CDC)
• Smart thermometer\u2013based surveillance to discern the role of children in household viral transmission during the\xa0COVID-19 pandemic\xa0(JAMA)
• COVID-19\xa0vaccine mandates (GOV)
• Changing epidemiology of adults\xa0hospitalized with COVID-19\xa0after introduction of vaccines (CID)
• Effectiveness\xa0of COVID-19 treatment with Nirmatrelvir\u2013Ritonavir or Molnupiravir among U.S. Veterans (ACP Journals)
• National trends in\xa0Anticoagulation therapy\xa0for COVID-19 (IDSA)
• Development\xa0of a definition of postacute sequelae of SARS-CoV-2 infection (JAMA)
• Neuroinflammation after\xa0COVID-19\xa0with depressive and cognitive symptoms (JAMA)
• Long COVID\xa0clinical phenotypes up to six months after infection identified by latent class analysis of self-reported symptoms (OFID)
• Coronary microvascular health in patients with\xa0prior COVID-19 infection\xa0(EACVI)
• Contribute to our\xa0FIMRC fundraiser at PWB
• Letters read\xa0on TWiV 1014
• Dr. Griffin\u2019s COVID treatment summary (pdf)
• Timestamps by\xa0Jolene. Thanks!

Intro music is by\xa0Ronald Jenkees

Send your questions for Dr. Griffin to daniel@microbe.tv